| 2023-10-18 |
详情>>
业绩披露：
2024年中报每股收益-24.02美元,归母净利润-13.27亿美元,同比去年增长-200.52%
|
| 2023-10-16 |
复牌提示：
2023-10-16 03:50:23 停牌，复牌日期 2023-10-16 16:44:00
|
| 2023-07-11 |
详情>>
股本变动：
变动后总股本5669.63万股
|
| 2023-07-11 |
详情>>
业绩披露：
2024年一季报每股收益-5.56美元,归母净利润-3.07亿美元,同比去年增长-178.35%
|
| 2023-06-29 |
股东大会：
将于2023-08-18召开股东大会
会议内容 ▼▲
- 1.Election of six directors to hold office until the 2024 Annual Meeting of Stockholders
2.Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm
3.Advisory vote to approve the compensation of our named executive officers
4.Advisory vote on the frequency of future advisory votes to approve the compensation of our named executive officers
5.Approval of the amendments to the Rite Aid Corporation Amended and Restated Certificate of Incorporation to eliminate supermajority voting provisions
6.Consider and vote on a stockholder proposal to require an annual advisory vote on the compensation of Rite Aid’s directors, if properly presented at the Annual Meeting
7.Consider and vote on a stockholder proposal to adopt an executive compensation adjustment policy, if properly presented at the Annual Meeting
|
| 2023-06-29 |
财报披露：
美东时间 2023-06-29 盘前发布财报
|
| 2023-05-01 |
详情>>
业绩披露：
2023年年报每股收益-13.71美元,归母净利润-7.5亿美元,同比去年增长-39.27%
|
| 2023-05-01 |
详情>>
业绩披露：
2021年年报每股收益-1.69美元,归母净利润-9090.9万美元,同比去年增长79.90%
|
| 2023-01-04 |
详情>>
业绩披露：
2023年三季报(累计)每股收益-9.32美元,归母净利润-5.09亿美元,同比去年增长-240.41%
|
| 2022-10-05 |
详情>>
业绩披露：
2023年中报每股收益-8.11美元,归母净利润-4.41亿美元,同比去年增长-289.46%
|
| 2022-07-06 |
详情>>
业绩披露：
2023年一季报每股收益-2.03美元,归母净利润-1.1亿美元,同比去年增长-743.92%
|
| 2022-07-06 |
详情>>
业绩披露：
2022年一季报每股收益-0.24美元,归母净利润-1305.7万美元,同比去年增长79.45%
|
| 2022-06-10 |
股东大会：
将于2022-07-27召开股东大会
会议内容 ▼▲
- 1.Election of eight directors to hold office until the 2023 Annual Meeting of Stockholders
2.Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm
3.Advisory vote to approve the compensation of our named executive officers
4.Approval of an amendment to the Rite Aid Corporation Amended and Restated 2020 Omnibus Equity Incentive Plan
5.Approval of the amendments to the Rite Aid Corporation Amended and Restated Certificate of Incorporation to eliminate supermajority voting provisions
6.Consider and vote on a stockholder proposal, if properly presented at the Annual Meeting
|
| 2022-04-25 |
详情>>
业绩披露：
2022年年报每股收益-9.96美元,归母净利润-5.38亿美元,同比去年增长-492.33%
|
| 2022-01-05 |
详情>>
业绩披露：
2022年三季报(累计)每股收益-2.77美元,归母净利润-1.49亿美元,同比去年增长-106.34%
|
| 2021-10-05 |
详情>>
业绩披露：
2022年中报每股收益-2.1美元,归母净利润-1.13亿美元,同比去年增长-47.72%
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-05-20 |
股东大会：
将于2021-07-07召开股东大会
会议内容 ▼▲
- 1.Election of nine directors to hold office until the 2022 Annual Meeting of Stockholders
2.Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm
3.Advisory vote to approve the compensation of our named executive officers
4.Approval of the Rite Aid Corporation Amended and Restated 2020 Omnibus Equity Incentive Plan
|
| 2020-05-26 |
股东大会：
将于2020-06-08召开股东大会
会议内容 ▼▲
- 1.Elect eight directors to hold office until the 2021 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified;
2.Ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm;
3.Approve, on an advisory basis, the compensation of our named executive officers as presented in the proxy statement;
4.Approve the adoption of the Rite Aid Corporation 2020 Omnibus Equity Incentive Plan;
5.Transact such other business as may properly come before the Annual Meeting or any adjournment or postponement of the Annual Meeting.
|
| 2019-06-07 |
股东大会：
将于2019-07-17召开股东大会
会议内容 ▼▲
- 1.Elect eight directors to hold office until the 2020 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified;
2.Ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm;
3.Approve, on an advisory basis, the compensation of our named executive officers as presented in the proxy statement;
4.Consider and vote on a stockholder proposal, if properly presented at the Annual Meeting;
5.Transact such other business as may properly come before the Annual Meeting or any adjournment or postponement of the Annual Meeting.
|
| 2019-04-22 |
详情>>
拆分方案：
每20.0000合并分成1.0000股
|
| 2019-02-07 |
股东大会：
将于2019-03-21召开股东大会
会议内容 ▼▲
- 1.A proposal, which we refer to as the "reverse stock split proposal," to adopt and approve an amendment to our Amended and Restated Certificate of Incorporation to effect (a) a reverse stock split of our outstanding shares of common stock, at a reverse stock split ratio of 1-for-10, 1-for-15 or 1-for-20, as determined by our Board of Directors at a later date, and (b) a reduction in the number of authorized shares of Rite Aid's common stock by a corresponding ratio.
2.A proposal, which we refer to as the "adjournment proposal," to approve, if necessary, the adjournment of the Special Meeting to solicit additional proxies in favor of the reverse stock split proposal.
|
| 2018-09-27 |
股东大会：
将于2018-10-30召开股东大会
会议内容 ▼▲
- 1.Elect nine directors to hold office until the 2019 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified;
2.Ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm;
3.Approve, on an advisory basis, the compensation of our named executive officers as presented in the proxy statement;
4.Consider and vote on three stockholder proposals, if properly presented at the Annual Meeting;
5.Transact such other business as may properly come before the Annual Meeting or any adjournment or postponement of the Annual Meeting.
|
| 2018-07-17 |
详情>>
内部人交易：
Abelman David等共交易7笔
|
| 2017-06-07 |
股东大会：
将于2017-07-17召开股东大会
会议内容 ▼▲
- 1.Elect nine directors to hold office until the 2018 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified;
2.Ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm;
3.Approve, on an advisory basis, the compensation of our named executive officers as presented in the proxy statement;
4.Recommend, on an advisory basis, the frequency of future advisory votes to approve the compensation of our named executive officers;
5.Transact such other business as may properly come before the Annual Meeting or any adjournment or postponement of the Annual Meeting.
|
| 2016-05-13 |
股东大会：
将于2016-06-22召开股东大会
会议内容 ▼▲
- 1.Elect nine directors to hold office until the 2017 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified;
2.Ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm;
3.Approve, on an advisory basis, the compensation of our named executive officers as presented in the proxy statement;
4.Transact such other business as may properly come before the Annual Meeting or any adjournment or postponement of the Annual Meeting.
|
| 2015-12-21 |
股东大会：
将于2016-02-04召开股东大会
会议内容 ▼▲
- 1.To consider and vote on the proposal to adopt the Agreement and Plan of Merger, dated as of October 27, 2015, which we refer to as the merger agreement, among Walgreens Boots Alliance, Inc., which we refer to as WBA, Victoria Merger Sub, Inc., which we refer to as Merger Sub and which is a wholly owned direct subsidiary of WBA, and Rite Aid, as it may be amended from time to time (a copy of the merger agreement is attached as Annex A to the proxy statement accompanying this notice);
2.To consider and vote on the proposal to approve, by means of a non-binding, advisory vote, compensation that will or may become payable by Rite Aid to its named executive officers in connection with the merger contemplated by the merger agreement;
3.To consider and vote on the proposal to approve one or more adjournments of the special meeting to a later date or dates, if necessary or appropriate, to solicit additional proxies if there are insufficient votes to adopt the merger agreement at the time of the special meeting;
4.To transact any other business that may properly come before the special meeting or any adjournment or postponement of the special meeting.
|
| 2015-05-15 |
股东大会：
将于2015-06-25召开股东大会
会议内容 ▼▲
- 1. Elect nine directors to hold office until the 2016 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified;
2. Ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm;
3. Approve, on an advisory basis, the compensation of our named executive officers as presented in the proxy statement;
4. Consider and vote on stockholder proposals, if properly presented at the Annual Meeting;
5. Transact such other business as may properly come before the Annual Meeting or any adjournment or postponement of the Annual Meeting.
|
| 2014-05-19 |
股东大会：
将于2014-06-19召开股东大会
会议内容 ▼▲
- 1. Elect eight directors to hold office until the 2015 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified;
2. Ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm;
3. Approve, on an advisory basis, the compensation of our named executive officers as presented in the proxy statement;
4. Approve the adoption of the Rite Aid Corporation 2014 Omnibus Equity Incentive Plan;
5. Consider and vote on a stockholder proposal, if properly presented at the Annual Meeting;
6. Transact such other business as may properly come before the Annual Meeting or any adjournment or postponement of the Annual Meeting.
|